Saxagliptin/metformin extended release - AstraZeneca
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Class Adamantanes; Antihyperglycaemics; Biguanides; Cycloparaffins; Dipeptides; Insulin sensitisers; Nitriles; Organic bridged compounds; Piperidines; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors; Glucose modulators
- USA Patent Applicants ASTRAZENECA AB
- USA Patents 4
- NDAs 1
- International Patents 57
- Patent Applications 153
Disclaimer